The PE Ratio as of November 2024 (TTM) for Diffusion Pharmaceuticals Inc. (DFFN) is -0.62

According to Diffusion Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.62. This represents a change of -173.75% compared to the average of 0.84 of the last 4 quarters.

Diffusion Pharmaceuticals Inc. (DFFN) Historical PE Ratio (quarterly & annually)

How has DFFN PE Ratio performed in the past?

The mean historical PE Ratio of Diffusion Pharmaceuticals Inc. over the last ten years is -2.69. The current -0.62 PE Ratio has changed 2.20% with respect to the historical average. Over the past ten years (40 quarters), DFFN's PE Ratio was at its highest in in the December 2017 quarter at 2.31K. The PE Ratio was at its lowest in in the December 2019 quarter at -15438.76.

Diffusion Pharmaceuticals Inc. (DFFN) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Diffusion Pharmaceuticals Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Diffusion Pharmaceuticals Inc. (DFFN) Average PE Ratio

How has DFFN PE Ratio performed in the past?

The current PE Ratio of Diffusion Pharmaceuticals Inc. (DFFN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Diffusion Pharmaceuticals Inc. (DFFN) PE Ratio vs. Peers

How is DFFN’s PE Ratio compared to its peers?

Diffusion Pharmaceuticals Inc.’s PE Ratio is less than Bio-Path Holdings, Inc. (-0.24), greater than Catalyst Biosciences, Inc. (-4.80), less than Capricor Therapeutics, Inc. (-0.05), less than NextCure, Inc. (-0.57), less than Tonix Pharmaceuticals Holding Corp. (-0.09), less than Jaguar Health, Inc. (-0.26), greater than Acasti Pharma Inc. (-3.10), greater than iBio, Inc. (-0.98), less than Pulmatrix, Inc. (0), greater than Akari Therapeutics, Plc (-2.31), greater than Soleno Therapeutics, Inc. (-0.81), greater than Cellectar Biosciences, Inc. (-18.45), greater than Monopar Therapeutics Inc. (-1.39), less than Tenax Therapeutics, Inc. (-0.54), less than null (108.67),

Build a custom stock screener for Diffusion Pharmaceuticals Inc. (DFFN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Diffusion Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Diffusion Pharmaceuticals Inc. (DFFN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Diffusion Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.